Verification evidence is still being completed.
PDF / print export
KBI Biopharma SA (Geneva)
Geneva, Switzerland
- Verified lead
- Ulrich Valley
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Senior Vice President, Operations and Site Head, Geneva
- 2026 technical specialization
- Biologics CDMO, Cell Line Development, and Integrated European Mammalian Manufacturing
- Review cycle
- 24 April 2026
- Full address
- Geneva, Switzerland (Selexis and KBI integrated biologics facility)
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- KBI Biopharma press release on the integrated Geneva biologics manufacturing facility.
- Editorial note
- Geneva integrated biologics CDMO with named site head, 94,000 square-foot operating footprint combining KBI manufacturing with Selexis cell line development inside JSR Life Sciences.
Biologics CDMO, Cell Line Development, and Integrated European Mammalian Manufacturing
JSR Life Sciences subsidiary, Integrated biologics CDMO operations, First-in-human manufacturing release record
Geneva integrated biologics CDMO with named site head, 94,000 square-foot operating footprint combining KBI manufacturing with Selexis cell line development inside JSR Life Sciences.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Geneva, Switzerland
KBI Biopharma SA (Geneva)
Biologics CDMO, Cell Line Development, and Integrated European Mammalian Manufacturing · Integrated biologics CDMO manufacturing
Geneva integrated biologics CDMO with named site head, 94,000 square-foot operating footprint combining KBI manufacturing with Selexis cell line development inside JSR Life Sciences.
- Lead
- Ulrich Valley (verified ↗)
- Address
- Geneva, Switzerland (Selexis and KBI integrated biologics facility) (source ↗)
- Compliance
- GMP
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Integrated biologics CDMO manufacturing
- Capabilities
- Mammalian Cell Line Development · Integrated Biologics Process and Analytical Development · European Mammalian Contract Manufacturing
- Founded
- 1994
- Headcount
- 1001-5000
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED APRIL 2026
Ulrich Valley
Senior Vice President, Operations and Site Head, Geneva
Full addressGeneva, Switzerland (Selexis and KBI integrated biologics facility)
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Integrated biologics CDMO manufacturing
Geneva, Switzerland. Biologics CDMO, Cell Line Development, and Integrated European Mammalian Manufacturing. Review completed on 24 Apr 2026.
Swissmedic and FDA for CDMO oversight
JSR Life Sciences subsidiary, Integrated biologics CDMO operations, First-in-human manufacturing release record
Biologics CDMO, Cell Line Development, and Integrated European Mammalian Manufacturing
Geneva integrated biologics CDMO with named site head, 94,000 square-foot operating footprint combining KBI manufacturing with Selexis cell line development inside JSR Life Sciences.
Editorial note
KBI Biopharma's Geneva site (co-located with Selexis SA) provides integrated cell line development, process development, and biologics manufacturing in Europe, with a named site head and JSR Life Sciences parent backing.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Mammalian Cell Line Development
Integrated Biologics Process and Analytical Development
European Mammalian Contract Manufacturing
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Cell line development suites
Mammalian process development
Analytical and QC laboratories
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is KBI Biopharma SA (Geneva) located?
- KBI Biopharma SA (Geneva) operates from Geneva, Switzerland (Selexis and KBI integrated biologics facility), Geneva, Switzerland.
- Who runs KBI Biopharma SA (Geneva)?
- KBI Biopharma SA (Geneva) is led by Ulrich Valley, Senior Vice President, Operations and Site Head, Geneva. Verified 24 Apr 2026.
- What does KBI Biopharma SA (Geneva) do?
- Geneva integrated biologics CDMO with named site head, 94,000 square-foot operating footprint combining KBI manufacturing with Selexis cell line development inside JSR Life Sciences. Core capabilities: Mammalian Cell Line Development, Integrated Biologics Process and Analytical Development, European Mammalian Contract Manufacturing.
Editorial context
Related technical briefs
Briefs that name Geneva as a covered market or city.